Related Experiment Video

Updated: Aug 15, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.3K

Are post-influenza vaccine reactions truly 'adverse'?

Lajjaben Patel1, Neil Keshvani1, Ambarish Pandey1

  • 1Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.

European Journal of Heart Failure
|January 4, 2023
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
08:11

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Published on: September 6, 2016

18.9K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.8K

Related Experiment Videos

Last Updated: Aug 15, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.3K
Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
08:11

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Published on: September 6, 2016

18.9K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.8K

Related Concept Videos

Vaccinations01:51

Vaccinations

45.1K
Overview
45.1K
Pharmacovigilance01:19

Pharmacovigilance

949
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
949

Articles linked to this work by shared authors, journal, and citation graph.

Food Supplementation in Patients Hospitalized for Heart Failure: A Randomized Clinical Trial.

JAMA cardiology·2026

Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction.

JAMA cardiology·2026

Diuretic Resistance Risk and the Efficacy of Natriuresis-Guided Diuretic Therapy in Acute Heart Failure: Post Hoc Analysis From the PUSH-AHF Trial.

JACC. Heart failure·2026

Artificial Intelligence-Enabled Electrocardiography in Practice: A State-of-the-Art Review.

Korean circulation journal·2026

Cardio-Kidney-Metabolic Therapy Use Among Adults With Type 1 Diabetes and Chronic Kidney Disease.

Diabetes, obesity & metabolism·2026

Artificial intelligence bias in the prediction and detection of cardiovascular disease.

NPJ cardiovascular health·2026

Cost-effectiveness of digitoxin in heart failure with reduced ejection fraction in the European Union and the United States.

European journal of heart failure·2026

Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.

European journal of heart failure·2026

Treatment effects of dapagliflozin in patients with aortic stenosis undergoing transcatheter aortic valve implantation across left ventricular ejection fraction.

European journal of heart failure·2026

The C-MIC II Follow-Up Study: Safety and Efficacy Results 12 months After Deactivation of Cardiac Microcurrent Therapy.

European journal of heart failure·2026

Heart Failure and Cancer: Incidence and Mortality Patterns, A Systematic Review and Meta-analysis.

European journal of heart failure·2026

Strategies for preventing and reversing atrial cardiomyopathy (AtCM): current evidence, therapeutic targets, and future directions. A European Journal of Heart Failure expert consensus statement.

European journal of heart failure·2026

Atypical Fibrotic-Mimicking Pulmonary Sarcoidosis in a Young Female: The Basal Conundrum.

Respirology case reports·2026

Recurrent Bullous Pemphigoid: A Case Report.

Cureus·2026

Immunopathogenesis of itch: an integrative framework for chronic pruritus.

JID innovations : skin science from molecules to population health·2026

Peanut Oral Immunotherapy Updosing via In-Office, Video, and Telephone Encounters: Safety and Caregiver Satisfaction.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Rhinosinusitis in Adults Receiving Tumor Necrosis Factor Alpha Inhibitors and Anti-CD20 Therapy: A Scoping Review.

International forum of allergy & rhinology·2026

From Barrier Disruption and Immune Dysregulation to Targeted Therapies in Atopic Dermatitis.

Clinical reviews in allergy & immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us